Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Department of Health and Human Services ▸ National Institutes of Health
Description
The NHLBI is planning to release a funding opportunity for single site clinical trials that involve novel and innovative designs such as platform, adaptive, and Bayesian trials. These trials can focus on testing various therapeutic, behavioral, or prevention strategies. The trials must align with NHLBI's research goals and the NIH's clinical trial definition. Although applications are not being accepted yet, this notice is to give researchers ample time to form collaborations and plan projec…
The NHLBI intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. Trials using innovative…
Source
Grant ID
FOR-HL-25-028
Funding Source
Department of Health and Human Services ▸ National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- Independent school districts
- Public housing authorities/Indian housing authorities
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Native American tribal organizations (other than Federally recognized tribal governments)
- Small businesses
- Native American tribal governments (Federally recognized)
- Public and State controlled institutions of higher education
- County governments
Links
Similar opportunities
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- Notice of Funding Opportunity (NOFO) for Investigator-Initiated Single Site Clinical Trials
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
- NIAMS UG3/UH3 Cooperative Agreement for Clinical Trials